Yokohama, Japan

Akio Myoga

This inventor holds 1 USPTO granted patent. Top assignee: Dainabot Co., Ltd.. Active years: 1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akio Myoga. Retrieved from https://idiyas.com/inventor/akio-myoga

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Akio Myoga: Innovator in Cancer Detection

Introduction

Akio Myoga is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of medical diagnostics, particularly in cancer detection. His innovative approach has the potential to improve early diagnosis and treatment outcomes for patients.

Latest Patents

Myoga holds a patent for a method for the detection of cancer. This process involves an immunological assay of a glycolipid present in blood, thoracic cavity fluid, abdominal dropsy, or urine. The glycolipid can be selected from a specific group, showcasing the targeted nature of his invention.

Career Highlights

Myoga is associated with Dainabot Co., Ltd., where he continues to work on advancements in medical technology. His dedication to research and development has positioned him as a key figure in his field.

Collaborations

Some of his notable coworkers include Kenji Arai and Kiyoshi Sekiguchi. Their collaborative efforts contribute to the innovative environment at Dainabot Co., Ltd.

Conclusion

Akio Myoga's work in cancer detection exemplifies the impact of innovation in healthcare. His contributions are paving the way for more effective diagnostic methods, ultimately benefiting patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…